Evidence map›Paper›PMID 42691061›Full record

ArticlePloS one2026

High AUROC can mask decision failure in sepsis transcriptomic classifiers: Preprocessing stability outweighs post hoc calibration across cohorts.

Hongwei Zheng, Wenbiao Chen

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hongwei ZhengQuanzhou Medical College, Quanzhou, Fujian, People's Republic of China.ORCID https://orcid.org/0009-0002-6221-9828
Wenbiao ChenQuanzhou Medical College, Quanzhou, Fujian, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHigh AUROC is often taken as evidence that a transcriptomic classifier is promising, but rank discrimination can conceal fixed-threshold failure after cohort or platform transfer.

methodsWe benchmarked four GEO whole-blood cohorts: GSE65682 for discovery, GSE95233 for external microarray validation, GSE154918 for cross-platform RNA-seq validation, and GSE28750 for non-infectious inflammation stress testing. We compared logistic-regression workflows using training-derived standard scaling, training-derived robust scaling, sample-wise rank normalization with training-derived scaling, and robust scaling using unsupervised external-cohort reference statistics. Internal performance used five-fold cross-validation with fold-contained imputation and scaling. External uncertainty used 2,000 stratified bootstrap replicates.

resultsInternal discrimination was very high for all strategies, but external validation revealed threshold collapse for training-derived standard and robust scaling. In GSE154918, both had balanced accuracy 0.50 at the 0.5 threshold despite very high AUROC, equivalent to random classification at that fixed threshold. The strict-inductive sample-rank strategy preserved fixed-threshold performance across external cohorts (balanced accuracy 0.95-1.00). Robust external-cohort adaptation also performed well (0.95-1.00) but uses unlabeled external-cohort distribution statistics and is therefore reported as adaptation rather than fixed single-sample transfer. Calibration and regularization sensitivity did not rescue the failing training-derived scaling strategies. In the sepsis-versus-non-infectious-inflammation stress test, robust external-cohort adaptation had the highest observed balanced accuracy (0.80, 95% CI 0.61-0.95), but its difference from sample-rank normalization was uncertain in paired bootstrap analysis.

conclusionsHigh AUROC can mask fixed-threshold failure in sepsis transcriptomic classifiers. In this benchmark, strict-inductive sample-rank normalization was the most stable fixed external strategy, while robust external-cohort scaling was best interpreted as unsupervised cohort adaptation whose reliability depends on external reference-sample availability.

Indexed as

Gene Expression ProfilingSepsisTranscriptomeArea Under CurveCalibrationCohort StudiesHumansROC Curve

Identifiers

PMID42691061
PMCPMC13541173

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.